DRG:HYBRiD-XL® - A Fully Automated Analyzer for Immunoassay and Clinical Chemistry
We’ve had an excellent run with the DRG Hybrid XL in our lab space. The platform is compact, the interface is concise, the assays are robust, and the results are precise. Coming from a CLIA laboratory, I’ve had the opportunity to handle a number of tabletop and full-size chemistry analyzers. Put simply, the Hybrid is among the best.
– Julian O. Yerkes Biomarkers Lab, Emory University.
The DRG: HYBRiD-XL ® Unique, Fully Automated, Continuous Access Analyzer is Now Available!
Using innovative and unique technology the DRG HYBRiD-XL ® allows, for the first time, the simultaneous measurement of immunoassays and clinical chemistry parameters, including turbidimetric tests in one sample.
The lab top analyzer, ideal for medium-sized and small laboratories, provides diagnostic services to hospitals, clinics and large medical practice facilities.
Up to 40 tests of different types or 40 times of the same test, or up to 20-patient samples can be ordered by the medical practitioner over a wide range of pre-packaged tests to serve different specialties.
Color Monitor, Touchscreen (8.5 inch.)
Smart user guidance
Bi-directional Interface (ASTM)
Barcoded Master Curve
2 point recalibration
Up to 20 samples/run (12 primary tubes or 20 secondary tubes)
Random access possible
Reagents on board (cartridge ready to use)
Barcoded reading of samples and reagents
Serum, Plasma, Urine or Saliva samples
Sample dilution up to 1:1000
First results after 10 minutes
Up to 80 tests/hour (2 runs)
Long walk away times
Short hands-on times
Benchtop Analyzer (60,8 x 63,5 x 58,6 cm high)
Only 2 system-reagents (Wash/Needle cleaning)
Liquid level detection
Variable assay-sizes (24, 60, 120 tests)
News and Updates
DRG distributor “SERION-BRAZIL” successfully attends Brazilian Laboratory Medicine Exhibition in Sao Paulo, Brazil
DRG is proud to announce the new partnership with Serion-Brazil and looks forward to a longstanding and successful business relationship! Mr. Gustavo Ruales, DRG International's Latin American Sales Manager, also attended the exhibition to support...read more
We are proud to announce the launch of a new assays for DRG:HYBRiD-XL®: TM-CA 72-4. Clinical Application: Tumor Marker (gastrointestinal cancer) Tumor Marker (ovarian cancer) CA 72‑4 is the marker of choice for the therapeutic monitoring and follow-up...read more
New Poster presented using DRG´s newly optimized Salivary Testosterone Kit Ellie Shuo Jin, Doctoral Candidate in Clinical Psychology of the University of Texas at Austin, presented her poster at the Meeting of International Society of Psychoneuroendocrinology...read more
DRG is proud to announce that our TM-CA 72-4 ELISA Kit (EIA-5071) has been used in a recent cancer study done by NYU Winthrop Hospital. The DRG TM-CA 72-4 ELISA Kit is for sale in the United States as an RUO product and is CE marked for global sales. Please see...read more
DRG International, Inc., the authorized distributor for CHROMagar, recently attended the 2017 ASM Microbe General Meeting of the American Society for Microbiology in New Orleans, LA from June 1, 2017 – June 4, 2017. Attendees (pictured above, l to r) were Mr. Alberto...read more
Dear Customers, Suppliers, and Friends, We regret to inform you that Dr. Cyril E. Geacintov passed away on Tuesday, May 23. His death was sudden and unexpected. In his usual driven style he was working in the office until a few days ago and challenging his team on how...read more
DRG International, inc. recently launched our brand new Ecommerce site for USA customers! Click here to shop over 180 ELISA, Salivary ELISA, and CHROMagar products now: https://store.drg-international.com/ The Ecommerce store has over 180 products that are FDA...read more
DRG Booth with Visitors. From Left: Mr. Gideon Lim; Dr. Cyril E. Geacintov, CEO & Founder of DRG; Dr.Aw Tar Choon, MD at Changi General Hospital in Singapore; Mrs. Josephine Teo; Mrs. Elke Geacintov; Mr. Wilhelm Sanger. We are pleased to announce that the DRG...read more
DRG’s CA 72-4 ELISA Kit (EIA-5071), which uses antibodies licensed from the NIH, has been used in a recent study conducted by Winthrop University. The study used the DRG CA 72-4 ELISA Kit (EIA-5071) to explore the expression of CA72-4 compared to current FDA-approved...read more
DRG is pleased to officially announce that we are going to Medlab Dubai from February 6th-February 9th, 2017 at the Dubai International Convention & Exhibition Centre, attended by over 10,000 delegates. The conference features 11 CME-accredited conference...read more
We sat down with the top executives and staff of DRG at the 2016 AACC Annual Meeting and asked them questions about what makes them the worldwide leader in diagnostics. These are the key takeaways the top executives at DRG want you to remember. Michael Martini (full...read more
DRG’s staff is diverse and the company maintains a global presence requiring its staff to speak multiple languages as well as travel the world visiting DRG’s many offices and events. We sat down with the top executives and staff of DRG at the 2016 AACC Annual Meeting...read more